Umblical Cord Blood and Alpha-3 Fucosyl Transferase-Treated Haematopoietic Stem Cells for Transplantation
-
Published:2011-07-13
Issue:
Volume:
Page:157-162
-
ISSN:
-
Container-title:Stem Cells and Cancer Stem Cells, Volume 1
-
language:
-
Short-container-title:
Publisher
Springer Netherlands
Reference37 articles.
1. Ballen KK, Barker JN, Stewart SK, Greene MF, Lane TA, American Society of Blood and Marrow Transplantation (2008) Collection and preservation of cord blood for personal use. Biol Blood Marrow Transplant 14:356–363 2. Ballen KK, Spitzer TR, Yeap BY, McAfee S, Dey BR, Attar E, Haspel R, Kao G, Liney D, Alyea E, Lee S, Cutler C, Ho V, Soiffer R, Antin JH (2007) Double unrelated reduced‐intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant 13:82–89 3. Blaes AH, Cao Q, Wagner JE, Young JA, Weisdorf DJ, Brunstein CG (2010) Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after antithymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood transplantation. Biol Blood Marrow Transplant 16:287–291 4. Bengtson P, Lundblad A, Larson G, Påhlsson P (2002) Polymorphonuclear leukocytes from individuals carrying the G329A mutation in the 1,3-fucosyltransferase VII gene (FUT7) roll on E- and P-selectins. J Immunol 169:3940–3946 5. Broxmeyer HE, Hangoc G, Cooper S, Ribeiro RC, Graves V, Yoder M, Wagner J, Vadhan-Raj S, Benninger L, Rubinstein P, Randolph Broun E (1992) Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA 89:4109–4113
|
|